Aurinia Pharmaceuticals (AUPH)

P/S ratio as of January 2026 (TTM): 7.33

According to Aurinia Pharmaceuticals 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 5.33. At the end of 2025 the company had a P/S ratio of 6.51.

P/S ratio history for Aurinia Pharmaceuticals from 2009 to 2025

PS ratio at the end of each year

Year	P/S ratio	Change
2025	6.51	16.15%
2024	5.60	-23.84%
2023	7.36	60.59%
2022	4.58	-92.96%
2021	65.0	86.98%
2020	34.8	-99.51%
2019	> 1000	462.36%
2018	> 1000	37.8%
2017	913	89.43%
2016	482	39.9%
2015	345	-15.79%
2014	409	752.87%
2013	48.0	2633.42%
2012	1.76	-91.88%
2011	21.6	81.59%
2010	11.9	58.19%
2009	7.53

P/S ratio for similar companies or competitors

Company	P/S ratio	P/S ratio differencediff.	Country
Regeneron Pharmaceuticals REGN	5.57	-23.96%	🇺🇸 USA
Aeterna Zentaris AEZS	2.77	-62.20%	🇺🇸 USA
Pieris Pharmaceuticals PIRS	0.9173	-87.49%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

P/S ratio for Aurinia Pharmaceuticals (AUPH)

P/S ratio as of January 2026 (TTM): 7.33